About US
Contact us
-
GSK to pay £297m fine over bribery case in ChinaGlaxoSmithKline (GSK) has been fined £297m by the Changsha Intermediate People's Court in Hunan Province, China, over bribery charges. The fine follows after GSK China Investment (GSKCI) was fo2014/9/22
-
Bayer brings $12.9B plastics spinoff to Big Pharma's slim-down partyBayer's drug business is booming. So much so that the German company has decided to put its focus squarely on its life sciences division: It plans to spin off its plastics unit within 18 months, takin2014/9/19
-
FDA backs ED upstart Stendra as a fast-acting alternative to ViagraIt's no picnic competing with a cultural phenom. Auxilium ($AUXL) and Vivus ($VVUS) know this well: Their new erectile dysfunction pillStendrahas to go up against Pfizer's ($PFE)Viagra. Competition fr2014/9/19
-
The FDA approved a new opioid-induced constipation treatment from partners AstraZeneca ($AZN) and Nektar Therapeutics ($NKTR)The FDA approved a new opioid-induced constipation treatment from partners AstraZeneca ($AZN) and Nektar Therapeutics ($NKTR), shaking off some safety concerns and green-lighting a drug the two hope c2014/9/18
-
Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates.Sutro Biopharma has landed another marquee name for its list of development partners for antibody-drug conjugates. Merck KGaA, which has been struggling in the clinic for years, has signed on with the2014/9/17
-
ROQUETTE China Launches Chinese Website(September16, 2014, Shanghai, China) ROQUETTE China is inviting visitors to explore its Chinese website. The new website was developed to provide the ultimate user-friendly experience with improved na2014/9/16
-
Meet Baxalta, the pharma spinoff Baxter plans to unleash in 2015When Abbott Laboratories ($ABT) told the world that its spun-off pharma business would bear the AbbVie ($ABBV) moniker, there were the usual marketing-speak explanations. Includes the name of its form2014/9/12
-
Pre-chemo nod for Medivation's Xtandi sets up showdown with J&J's ZytigaJohnson & Johnson's ($JNJ) next-gen prostate cancer pill,Zytiga, has been cruising since it hit the market back in April 2011, but now, it may be vulnerable to market share losses for the first ti2014/9/12
-
GSK partners with UK and South African research councils for NCDs in AfricaBritish drug-maker GlaxoSmithKline (GSK) has partnered with UK and South African medical research councils (MRC) to carry out research on non-communicable diseases (NCDs) in Africa. The £5m col2014/9/11
-
FDA grants approval for Keryx’s ferric citrate to treat dialysis patients with hyperphosphatemiaKeryx Biopharmaceuticals has received approval from the US Food and Drug Administration (FDA) for its ferric citrate (formerly known as Zerenex), a new oral iron-based treatment for dialysis patients2014/9/11